George Kelly Martin serves as Executive at TriSalus Life Sciences, Inc., where they oversee executive responsibilities. Since joining the company, George Kelly Martin has executed 1 insider transactions totaling $50, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 28, 2024 involved selling 9 shares valued at $50.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Aug 28, 2024 | TLSI | $50 | Sale | 9 | $5.50 | Discretionary |
George Kelly Martin currently holds 247,176 shares of TriSalus Life Sciences, Inc. (TLSI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, George Kelly Martin has been a net seller of TLSI stock. They have purchased $0 and sold $50 worth of shares.
George Kelly Martin's most recent insider trade was on Aug 28, 2024, when they sold 9 shares at $5.50 per share.
Get notified when new Form 4 filings are submitted